Month December 2024

ImmunityBio plans public inventory providing

CULVER CITY, Calif. – ImmunityBio, Inc. (NASDAQ: IBRX), a $3.2 billion market cap immunotherapy firm at present buying and selling at $4.64, introduced its intention to launch a public providing of its widespread inventory, topic to market situations. In response…